Navigation Links
Pearl Therapeutics Reports Positive Phase 2b Results of PT001 in Patients With COPD
Date:12/7/2011

REDWOOD CITY, Calif., Dec. 7, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler (GP MDI; PT001) in patients with moderate-to-severe COPD. Four doses of GP MDI were compared to placebo and Atrovent® HFA Inhalation Aerosol, a short-acting muscarinic antagonist given four times a day (QID). All doses of GP MDI tested produced statistically significant improvements in lung function (FEV1 AUC 0-12)(1) compared to placebo (p<0.0001). Further, doses of PT001 were identified that were non-inferior to Atrovent HFA. PT001 was well tolerated and no safety concerns were identified. This study complements Pearl's previous assessment of PT001's clinical profile relative to well established marketed muscarinic antagonists(2), and provides additional dose ranging data for glycopyrrolate component of Pearl's LAMA/LABA combination product, PT003. Detailed results of this Phase 2b study of PT001 will be presented at a future conference.

Dr. Colin Reisner, chief medical officer and executive vice president of clinical development for Pearl Therapeutics commented, "This Phase 2b study provides important information about the safety and efficacy of GP MDI, the LAMA component of PT003, our lead combination bronchodilator candidate for the treatment of COPD. Further, the activity profile of GP MDI in this study is consistent with that observed in two previously reported studies and supports the BID dosing that we believe will provide the best symptom relief for patients with moderate-to-severe COPD."

"A significant part of the very large COPD market is driven by the use of BID LABAs and inhaled corticosteroids.  However, a rapid-acting, BID LAMA to complement
'/>"/>

SOURCE Pearl Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform
2. Anthera Announces Last Patient Enrolled in PEARL-SC Study
3. Pearl Therapeutics Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
4. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
5. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
6. Pearl Therapeutics Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
7. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
8. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
9. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
10. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
11. Echo Therapeutics to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Medina Medical announced today ... member of the Board of Directors on August 18, ... development and commercialization experience, including over a decade of ... served as a Partner of the medical device incubator ... of two Foundry start-ups. Mr. Engelson previously served as ...
(Date:8/29/2014)... JORDAN, Utah , Aug. 29, 2014  BC ... Solutions, has acquired Polaris Medical Imaging, a leader in ... scanners. This strategic acquisition allows BC Technical to continue ... capabilities, specifically within MR and CT modalities. ... cost service," said Mark Alvarez , president and ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... conventional methods developed to prevent and eradicate the prevalence ... These methods are confined to low specificity, safety and ... to look for a better solution. It has been ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2BC Technical Acquires Polaris Medical Imaging 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2
... Guidance for 2010 -- HARBIN, China, Sept. 3 /PRNewswire-Asia-FirstCall/ -- ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... Technologies Clarifies the PR Issued on September 1 for the Stock... -- JERUSALEM, September 3, 2010 ... ... (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Medicine Technology:China Sky One Medical Updates Financial Guidance for 2010 2China Sky One Medical Updates Financial Guidance for 2010 3China Sky One Medical Updates Financial Guidance for 2010 4China Sky One Medical Updates Financial Guidance for 2010 5China Sky One Medical Updates Financial Guidance for 2010 6China Sky One Medical Updates Financial Guidance for 2010 7China Sky One Medical Updates Financial Guidance for 2010 8Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 2Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 3Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 4Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 5Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 6Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 7
(Date:8/31/2014)... Washington, D.C.USA (PRWEB) August 31, 2014 ... the global community utilizing social media marketing tools ... and interactive programs. MMU will utilize all tools ... become learning partner for our multiple learning channels. ... new mobile app, and an authoring tool that ...
(Date:8/31/2014)... Just in time for Washington’s Indian Summer, Dukes ... Salmon, award winning chowder and legendary sourdough bread ... location , Sunday, September 28, 2014 from 1 pm to ... BBQ culinary delights. Live music will add to the festive ... and Mexico will be featured. “There is no salmon ...
(Date:8/31/2014)... For many, fall turns daily life into an ... the most common cause of fall hay fever and affects ... symptoms of ragweed allergy include a stuffed up or runny ... also lead to wheezing, asthma attacks, and sinusitis. , Those ... allergy immunotherapy - the only treatment shown to change the ...
(Date:8/31/2014)... With years of hard work, Delta has now become ... Recently, the company has updated its wheel loader ... All these items are guaranteed to be great. Additionally, they ... It is true that all items in Delta’s used ... specialists. The firm is making full efforts to help worldwide ...
(Date:8/31/2014)... 2014 In the wake of growing ... proposed legislation to require mandatory labeling of GMOs on ... purchasing decisions that affect their own health and the ... for stringent measures to eliminate GMOs from dietary supplements, ... Engagement” (I.C.E.) initiative with the objective of advancing the ...
Breaking Medicine News(10 mins):Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3Health News:Seattle Seafood Restaurant Duke's Chowder House on Green Lake Will Celebrate The Long Anticipated Indian Summer With First Annual Sizzling BBQ Salmon Tasting Event. 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 3Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3
... ShelterATLANTA, Feb. 17 /PRNewswire/ -- ... Tyler Perry has donated $110,000 and a brand ... The funds will contribute to operating costs ... for homeless adolescents in Atlanta. (Photo: http://www.newscom.com/cgi-bin/prnh/20090217/NY71356 ...
... Cancer may well surpass cardiovascular,diseases as the primary case ... this from,happening, cancer therapeutics have to shift in focus ... despite the complex, multifactorial nature,of cancer indications. , ... "As cancer spreads rapidly through Europe, ...
... VeriFone Holdings,Inc. (NYSE: PAY ) ... been integrated with Secure EDI,s state-of-the-art platform to ... Secure EDI is a ... for medical, dental and institutional providers. The,company also ...
... PRINCETON, NJ, Feb. 17 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp., ... infection and inflammation, today announced its financial results for ... 2008. , For the quarter ended December 31, 2008, ... cents per share, on revenues of $5.8 million. This ...
... Geriatric Home Health CareMELVILLE, N.Y., Feb. 17 Gentiva ... leading provider of comprehensive home health services, announced today ... with Andventure Inc., doing business as Loving Care Agency ... offices in four cities that specialize in pediatric home ...
... PAREXEL Consulting, a business unit of ... global consultancy serving the biopharmaceutical and medical device industries, ... Principal Consultant in its European Product Development Practice. Dr. ... Medical Products Agency (MPA), will advise clients on all ...
Cached Medicine News:Health News:Tyler Perry Donates $110K to Covenant House Keeping Atlanta Teens off the Street 2Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 2Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 3Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 4Health News:Secure EDI Integrates VeriFone IPCharge in Real Time Patient Payment and Claims Processing Solutions Suite 2Health News:Secure EDI Integrates VeriFone IPCharge in Real Time Patient Payment and Claims Processing Solutions Suite 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 2Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 4Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 5Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 6Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 7Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 8Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 9Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 2Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 3Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 4Health News:PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil 2Health News:PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil 3Health News:PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil 4Health News:PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil 5
... therapeutic benefits of controlled compression and cold, ... pain. The anatomically designed cuff provides complete ... can be ordered with an extra long ... circumferences.,All Cryo/Cuffs can be ordered as a ...
... FUNCTIONAL ARM BRACE (FAB) was designed ... to make it useful as a ... ,Far more than an "Elbow ROM ... over forearm rotation (pronation and supination)., ...
... night splint features a completely padded ... dorsiflexion, designed to provide passive flexion ... plantar fasciitis or Achilles tendonitis. ... to order left or right. ...
Designed for forefoot relief and healing. This shoe has a unique wedge outsole and a soft nylon upper. We also added the hi-top upper to keep the foot held back and reduce slippage. Available in five...
Medicine Products: